British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)

被引：164

作者：

Gazzard, B. ^{[1
]}

机构：

[1] Chelsea & Westminster Hosp, London SW10 9NH, England

来源：

HIV MEDICINE | 2006年 / 7卷 / 08期

关键词：

D O I：

10.1111/j.1468-1293.2006.00424.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：487 / 503

页数：17

共 83 条

[51] Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults - Results of the ziagen once doily in antiretrovirol combinotion study [J].

Moyle, GJ ;

DeJesus, E ;

Cahn, P ;

Castillo, SA ;

Zhao, H ;

Gordon, DN ;

Craig, C ;

Scott, TR .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (04) :417-425

[52] Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in anti retroviral-naive subjects: 48-week results [J].

Murphy, RL ;

Sanne, I ;

Cahn, P ;

Phanuphak, P ;

Percival, L ;

Kelleher, T ;

Giordano, M .

AIDS, 2003, 17 (18) :2603-2614

[53] The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs [J].

Murray, JS ;

Elashoff, MR ;

Iacono-Connors, LC ;

Cvetkovich, TA ;

Struble, KA .

AIDS, 1999, 13 (07) :797-804

[54] Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy [J].

Nijhuis, M ;

Schuurman, R ;

de Jong, D ;

Erickson, J ;

Gustchina, E ;

Albert, J ;

Schipper, P ;

Gulnik, S ;

Boucher, CAB .

AIDS, 1999, 13 (17) :2349-2359

[55] Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count >350 X 106/l [J].

Opravil, M ;

Ledergerber, B ;

Furrer, H ;

Hirschel, B ;

Imhof, A ;

Gallant, S ;

Wagels, T ;

Bernasconi, E ;

Meienberg, F ;

Rickenbach, M ;

Weber, R .

AIDS, 2002, 16 (10) :1371-1381

[56]

PALLELA JF, 2003, ANN INTERN MED, V138, P320

[57] Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis [J].

Palmer, S ;

Kearney, M ;

Maldarelli, F ;

Halvas, EK ;

Bixby, CJ ;

Bazmi, H ;

Rock, D ;

Falloon, J ;

Davey, RT ;

Dewar, RL ;

Metcalf, JA ;

Hammer, S ;

Mellors, JW ;

Coffin, JM .

JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (01) :406-413

[58]

PODZAMCER D, 2005, 12 C RETR OPP INF BO

[59] Effect of persistent moderate viremia on disease progression during HIV therapy [J].

Raffanti, SP ;

Fusco, JS ;

Sherrill, BH ;

Hansen, NI ;

Justice, AC ;

D' Aquila, R ;

Mangialardi, WJ ;

Fusco, GP .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (01) :1147-1154

[60] Impact of an adherence clinic on behavioral outcomes and virologic response in the treatment of HIV infection: A prospective, randomized, controlled pilot study [J].

Rathbun, RC ;

Farmer, KC ;

Stephens, JR ;

Lockhart, SM .

CLINICAL THERAPEUTICS, 2005, 27 (02) :199-209

← 1 2 3 4 5 6 7 8 9 →